|
FDA Expands Scope of Guidance on Presubmission Meetings
Under a new draft guidance, the FDA’s Pre-IDE Program will be renamed the Pre-Submission Program and cover a broad range of applications — from IDEs, PMAs and 510(k)s to humanitarian device exemptions, de novo filings and more.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives